Literature DB >> 9651525

Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor.

Z S Xiao1, R Thomas, T K Hinson, L D Quarles.   

Abstract

Although the CBFA1 gene encodes an osteoblast-specific transcription factor that regulates osteoblast differentiation, uncertainty exists about the organization of its 5' end and the relevance of a novel N-terminal sequence identified in the mouse Cbfa1/Osf2 isoform. We found the novel 5' Cbfa1/Osf2 sequence is encoded by a previously unrecognized upstream exon, designated exon -1, which is highly conserved in mouse, rat and human. In addition, two splice donor sites may be utilized to generate Cbfa1/Osf2 cDNAs containing different N-terminal sequences. The first ATG and splice donor site in exon -1 is predicted to transcribe a cDNA containing the unique Osf2 5' sequence, whereas a second donor splice site gives rise to cDNAs that contain sequences encoding an 11 amino acid insert. In the human CBFA1 gene, an additional 2-bp nucleotide insert shifts the reading frame and results in stop codons in the cDNA sequence derived from exon -1. The 5'-most exon of the human CBFA1 gene, therefore, contains the 5' non-coding region rather than a human OSF2 homolog. The absence of a homologous OSF2 coding sequence in the human CBFA1 cDNA suggests that the novel mouse N-terminal Osf2 sequence is not essential for functioning of the CBFA1 gene product. In addition, multiple transcripts derived from a single CBFA1/Cbfa1 gene were detected in osteoblasts by Northern analysis and RT-PCR, including additional Cbfa1/Osf2 isoforms containing deletions of exons 1 and 4. Thus, the alternative use of transcription start sites and splicing leads to the genesis of CBFA1/Cbfa1 isoforms with possible differences in transactivation potentials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651525     DOI: 10.1016/s0378-1119(98)00227-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

1.  Identification of USF2 as a key regulator of Runx2 expression in mouse pluripotent mesenchymal D1 cells.

Authors:  Chihuei Wang; Grace Lee; Wayne Hsu; Ching-Hua Yeh; Mei-Ling Ho; Gwo-Jaw Wang
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

2.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

3.  A proximal activator of transcription in epithelial-mesenchymal transition.

Authors:  Christo D Venkov; Andrew J Link; Jennifer L Jennings; David Plieth; Tsutomu Inoue; Kojiro Nagai; Carol Xu; Yoana N Dimitrova; Frank J Rauscher; Eric G Neilson
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.

Authors:  Oxana P Lazarenko; Sylwia O Rzonca; Larry J Suva; Beata Lecka-Czernik
Journal:  Bone       Date:  2005-08-30       Impact factor: 4.398

5.  Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.

Authors:  M J Jiménez; M Balbín; J M López; J Alvarez; T Komori; C López-Otín
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.

Authors:  Mario Galindo; Jitesh Pratap; Daniel W Young; Hayk Hovhannisyan; Hee-Jeong Im; Je-Yong Choi; Jane B Lian; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

7.  Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells.

Authors:  Qiang Huang; Hui Zhang; Fu-xing Pei; Zhi-yu Chen; Guang-lin Wang; Bin Shen; Jing Yang; Zong-ke Zhou; Qing-quan Kong
Journal:  Int Orthop       Date:  2009-12-05       Impact factor: 3.075

8.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

9.  Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts.

Authors:  Christopher K Hee; Steven B Nicoll
Journal:  J Orthop Res       Date:  2009-02       Impact factor: 3.494

10.  Initial Characterization of Osteoblast Differentiation and Loss of RUNX2 Stability in the Newly Established SK11 Human Embryonic Stem Cell-Derived Cell Line.

Authors:  Jia-Li Yu; Helty Adisetiyo; Gillian H Little; C Thomas Vangsness; Jianjie Jiang; Hal Sternberg; Michael D West; Baruch Frenkel
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.